We are live on ! Find out more
Sanders Capital

Sanders Capital Portfolio holdings

AUM $99.8B
1-Year Est. Return 47.9%
This Fund
S&P 500
This Quarter Est. Return
+3.76%
1 Year Est. Return
+47.9%
3 Year Est. Return
+147.14%
5 Year Est. Return
+192.43%
10 Year Est. Return
+815.46%
AUM
$22.3B
AUM Growth
+$512M
Cap. Flow
-$87.8M
Cap. Flow %
-0.39%
Top 10 Hldgs %
54.73%
Holding
40
New
–
Increased
14
Reduced
22
Closed
–
Avg Time Held
17.2 quarters
Top 10 Avg Time Held
8.7 quarters
Top 20 Avg Time Held
12.3 quarters

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$185M
2
ELV icon
Elevance Health
ELV
+$27.2M
3
C icon
Citigroup
C
+$19.8M
4
BAC icon
Bank of America
BAC
+$18.7M
5
CI icon
Cigna
CI
+$15.7M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$173M
2
DHI icon
D.R. Horton
DHI
+$55.2M
3
TSM icon
TSMC
TSM
+$47.2M
4
AAPL icon
Apple
AAPL
+$46.5M
5
GILD icon
Gilead Sciences
GILD
+$21.4M

Sector Composition

Rank Sector Weight
1 Technology 24.29%
2 Healthcare 20.61%
3 Financials 15.87%
4 Communication Services 13.04%
5 Consumer Discretionary 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AAPL icon
1
Apple
AAPL
$4.98T
$1.83B 8.2%
32,614,564
-889,892
-3% -$46.5M
2013 Q3
24 quarters
MSFT icon
2
Microsoft
MSFT
$4.04T
$1.7B 7.63%
12,217,263
-66,619
-0.5% -$9.16M
2013 Q2
25 quarters
TSM icon
3
TSMC
TSM
$2.31T
$1.66B 7.47%
35,807,997
-1,106,910
-3% -$47.2M
2014 Q3
20 quarters
GOOG icon
4
Alphabet (Google) Class C
GOOG
$4.27T
$1.53B 6.86%
25,058,260
-286,240
-1% -$16.9M
2016 Q3
12 quarters
DHI icon
5
D.R. Horton
DHI
$37.9B
$1.11B 5%
21,121,218
-1,157,419
-5% -$55.2M
2013 Q4
23 quarters
UNH icon
6
UnitedHealth
UNH
$339B
$1.01B 4.53%
4,638,364
+11,698
+0.3% +$2.82M
2013 Q2
25 quarters
WFC icon
7
Wells Fargo
WFC
$244B
$892M 4%
17,682,550
+135,812
+0.8% +$6.4M
2018 Q2
5 quarters
PFE icon
8
Pfizer
PFE
$162B
$847M 3.8%
24,856,081
+5,094,551
+26% +$185M
2015 Q4
15 quarters
SU icon
9
Suncor Energy
SU
$88B
$825M 3.7%
26,109,084
-69,532
-0.3% -$2.09M
2018 Q2
5 quarters
CAT icon
10
Caterpillar
CAT
$355B
$789M 3.54%
6,246,810
+3,310
+0.1% +$421K
2018 Q4
3 quarters
BAC icon
11
Bank of America
BAC
$377B
$744M 3.34%
25,509,528
+651,057
+3% +$18.7M
2013 Q2
25 quarters
C icon
12
Citigroup
C
$209B
$735M 3.3%
10,645,595
+290,647
+3% +$19.8M
2013 Q2
25 quarters
CI icon
13
Cigna
CI
$74.7B
$711M 3.19%
4,685,643
+96,626
+2% +$15.7M
2013 Q2
25 quarters
GILD icon
14
Gilead Sciences
GILD
$183B
$710M 3.19%
11,198,093
-327,940
-3% -$21.4M
2017 Q3
8 quarters
META icon
15
Meta Platforms (Facebook)
META
$1.94T
$690M 3.1%
3,876,280
-12,520
-0.3% -$2.38M
2018 Q3
4 quarters
VZ icon
16
Verizon
VZ
$181B
$686M 3.08%
11,365,140
+258,740
+2% +$14.9M
2018 Q3
4 quarters
MDT icon
17
Medtronic
MDT
$119B
$665M 2.98%
6,117,877
-16,608
-0.3% -$1.73M
2013 Q2
25 quarters
LEN icon
18
Lennar Class A
LEN
$17.8B
$628M 2.82%
11,612,294
+66,602
+0.6% +$3.25M
2014 Q4
19 quarters
ELV icon
19
Elevance Health
ELV
$92.2B
$551M 2.47%
2,295,671
+99,124
+5% +$27.2M
2013 Q2
25 quarters
FITB icon
20
Fifth Third Bancorp
FITB
$45.5B
$520M 2.33%
18,987,765
-64,720
-0.3% -$1.77M
2014 Q2
21 quarters
JPM icon
21
JPMorgan Chase
JPM
$881B
$517M 2.32%
4,392,776
-741
-0% -$83.8K
2013 Q2
25 quarters
PEP icon
22
PepsiCo
PEP
$173B
$450M 2.02%
3,281,347
+2,860
+0.1% +$380K
2017 Q1
10 quarters
HAL icon
23
Halliburton
HAL
$27.3B
$445M 2%
23,611,761
-316,641
-1% -$6.55M
2017 Q4
7 quarters
SPY icon
24
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$395M 1.77%
1,331,623
-10,000
-0.7% -$2.95M
2013 Q2
25 quarters
BP icon
25
BP
BP
$125B
$252M 1.13%
6,636,206
+57,078
+0.9% +$2.18M
2013 Q2
25 quarters

Similar funds

Sanders Capital's Q3 2019 Portfolio in Review

As of Q3 2019, Sanders Capital held 40 positions worth $22.3B, up 2.4% from $21.8B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 0%. Sanders Capital opened no new positions and made no exits, leaving the 40-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Sanders Capital added most to Pfizer in Q3 2019, an estimated $185M increase.
  • Sanders Capital's biggest Q3 2019 reduction was Merck, cutting an estimated $173M.
  • Sanders Capital's ten largest holdings make up 55% of its $22.3B portfolio in Q3 2019.
  • Sanders Capital opened 0 new positions and closed 0 in Q3 2019.
  • Sanders Capital's portfolio value rose 2.4% quarter-over-quarter to $22.3B.

Based on Sanders Capital's 13F filing for Q3 2019, filed 13 Nov 2019.